Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17 clinical trials
Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis

connective tissue disorder [UCTD], Sjogren, antiphospholipid syndrome - APS, vasculitides, systemic lupus erythematosus [SLE], polymyositis, Hashimoto, multiple sclerosis, primary biliary

  • 11 views
  • 07 Nov, 2020
  • 1 location
Hydroxychloroquine and Unexplained Recurrent Miscarriage

perinatal outcomes such as systemic lupus erythematosus, antiphospholipid syndrome and placental inflammatory lesions such as chronic histiocytic intervillositis, hydroxychloroquine has therapeutic

  • 28 views
  • 23 Jan, 2021
  • 1 location
COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS

Patients with chronic rheumatic diseases (such as systemic lupus erythematosus [SLE], rheumatoid arthritis [RA], ankylosing spondylitis [AS], juvenile idiopathic arthritis [JIA], poly/dermatomyositis [PM/DM], systemic sclerosis [SSc], systemic vasculitis, and primary Sjgren's syndrome [pSS]) are particularly susceptible to infectious diseases due to autoimmune disorder itself and its treatment (immunosuppressive therapies). Similarly, …

  • 0 views
  • 01 Apr, 2021
  • 1 location
Use of Warfarin After the First Trimester in Pregnant Women With APS

Evaluation of shifting to oral vitamin K antagonist after the first trimester instead of using low molecular weight heparin (LMWH) throughout pregnancy in pregnant women with antiphospholipid

heparin
early pregnancy
vitamin
warfarin
vitamin k antagonist
  • 135 views
  • 24 Jan, 2021
  • 2 locations
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

antiphospholipid syndrome (APS) and repeatedly positive tests for lupus anticoagulant (LAC) to determine if this regimen will improve pregnancy outcomes. All enrolled patients will receive certolizumab, and

aspirin
heparin
anticoagulant
tumor necrosis factor-alpha
certolizumab pegol
  • 182 views
  • 10 Apr, 2021
  • 3 locations
Hydroxychloroquine for Prevention of Recurrent Miscarriage.

Antiphospholipid Syndrome. Hydroxychloroquine (HQ) is a molecule whose properties (anti-thrombotic, vascular-protective, immunomodulatory, improved glucose tolerance, lipid-lowering, anti-infectious) could

aspirin
miscarriage
antiphospholipid antibodies
thrombophilia
heparin
  • 198 views
  • 23 Jan, 2021
  • 25 locations
Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)

The aim of this study is to improve treatment of Moderate Aplastic Anemia (MAA) by evaluating the safety and efficiency of Eltrombopag as a new treatment option in patients with therapy requiring MAA.

eltrombopag
platelet count
platelet transfusion
neutrophil count
hypocellular bone marrow
  • 50 views
  • 22 Jan, 2021
Optimizing Gestational Weight Gain Birth Weight and Other Perinatal Outcomes Among Pregnant Women at Risk of Hypertension in Pregnancy

Background Burden: Hypertensive disorders of pregnancy, including preeclampsia, complicate up to 10% of pregnancies worldwide, constituting one of the greatest causes of fetal growth restriction, preterm birth, low birth weight, perinatal mortality, and maternal morbidity and mortality. In Bangladesh, 24% of all maternal deaths are directly attributed to hypertensive causes. …

premature birth
self monitoring
prenatal
intrauterine growth retardation
high risk pregnancy
  • 3 views
  • 26 Feb, 2021
  • 1 location
Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome

Antiphospholipid antibody syndrome (APS) is characterized by the presence of antiphospholipid antibodies, which are proteins in the blood that interfere with the body's ability to perform normal

premature birth
miscarriage
lupus
anticoagulant
coagulopathy
  • 431 views
  • 25 Jan, 2021
  • 1 location
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

complement split products) that can injure healthy organs can be used to predict poor pregnancy outcome in patients with systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS), and/or 2) to

miscarriage
lupus
antiangiogenic
antiphospholipid syndrome
fetal death
  • 323 views
  • 25 Jan, 2021
  • 10 locations